Aortic aneurysm is a common disorder, and it is due to weakening of the aortic wall due to weak collagen properties[@b1] or due to excess action of matrix metalloproteinase in certain patients[@b2]. Aneurysm rupture is a potentially life threatening complication[@b3].

The treatment of aortic aneurysm would be by beta-blockers in initial stages, which reduce the aortic wall dP/dT (rate of change in the aortic wall pressure/rate of change of time) or rate of the rise of the aortic wall pressure[@b3][@b4]. Exclusion of aneurysm by Dacron or PTFE (Polytetrafluroethylene) covered stent graft is a desirable treatment of choice at present in these patients. However, this has potential limitations such as side branch occlusion, endoleaks, paraplegia, device malfunctions and mal-appositions[@b5][@b6][@b7][@b8][@b9][@b10]. Endoleaks are seen in about 29% of the cases with endovascular repair[@b8]. There are difficulties in stent graft deployment and the procedure also requires adequate expertise and accuracy in deployment. Also, these stent grafts are bulky and have a large crimp profile. Femoral arteriotomy for vascular access by a surgeon would be frequently required in these patients before deployment. Flow exclusion by a multilayered nitinol model is another method of treatment of aneurysms and dissections of aorta[@b11][@b12]. We investigated a simple self-expanding Nitinol stent in the treatment of aortic aneurysms, and its effect on the aneurysm and aortic wall stress parameters. In this stent method, the flow was not excluded but instead the method preserves the existing aneurysm wall, and we analyzed the ability of the stent to absorb the stresses and strains in the aneurysm wall like a pillar.

Results
=======

Buckling characteristics
------------------------

The buckling characteristics of the stent by cross sectional analysis after deployment in the aneurysm model is shown in [figure 1](#f1){ref-type="fig"}. Stents with straight pattern buckle during deployment if cell size is \<\~10 mm, and with helical pattern buckle during deployment if cell size \<\~8 mm.

Stress-strain, deployment and properties
----------------------------------------

The principal and the peak-wall stresses, and the contact pressures before and after stent deployment of the 70/70 μm at 0 mmHg, and 100 mmHg are summarized in [figure 2](#f2){ref-type="fig"}. At 0 mmHg, the principal stresses, and the peak wall stresses were negligible on the surface of the stent. The results of the 70/70 μm stent deployed in the aneurysm wall, and the effect of the stent on the maximal stresses and strain are summarized in [figure 3](#f3){ref-type="fig"}. The stent could be deployed easily in the aneurysm model without redundancy. The stent apposes well on the aneurysm wall, and there was no buckling of the stent. There were only minimal stresses in the aneurysm and the adjacent aortic wall. There were no changes in strain parameters after stenting. There was good contact of the aortic wall and the stent. The observations demonstrated the efficacy of the stent, and its benign stress characteristics on the aneurysm wall after deployment. There was no change in aneurysm size after 70/70 μm stent deployment, which was an important observation to demonstrate the efficacy of the stent in stage 1 analysis.

Migration and crimp characteristics
-----------------------------------

There was no migration of the stent when studied at a blood pressure (BP) of 180 mmHg. This stent could be crimped in a 9 F catheter. This is due to lesser metal load and larger cell widths and absence of Dacron cover when compared to conventional endovascular stents. This advantage would be very useful to the interventionist as the procedure could be easily performed through percutaneous route even by basic interventionists.

Radial force evaluation
-----------------------

Results of the radial force evaluation ([figure 4](#f4){ref-type="fig"}) of the stent showed a minimal radial force on the aortic wall of the 70/70 and 180/100 μm. The radial force was highest in 300/150 μm stent, when compared to stents with other strut dimensions. The radial force was markedly low in the 70/70 μm stent. Cell widths did not affect the radial forces for the 70/70 μm and 180/100 μm stents. However, in the 300/150 μm stent, higher cell widths (7.9 and 9.5 mm) were associated with higher radial strength. Hence, the 300/150 μm stent had desirable stress characteristics and adequate radial force at 9 mm cell widths. The commercially available self-expanding stents have a radial force of 2 to 5 N.

Stage 2 results of 300/150 μm stent after embedding
---------------------------------------------------

Stage 2 study results with 300/150 μm stent model after embedding in the aortic wall with tissue overgrowth are shown in [figure 5](#f5){ref-type="fig"}. In the panels 3 and 4, the peak wall stresses were remarkably lesser after embedding the stent than in other panels before and after stent deployment. The stent reduced the peak wall stress by 70% in the aneurysm after a tissue overgrowth of 1 mm over the stent struts ([Figure 5](#f5){ref-type="fig"}). Also, there was a 1.2 mm increase in the aneurysm size after deployment of the stent. This is a very mild increase in aneurysm size, which is not desirable. However, this occurs at a significant fall in wall stresses, which is very advantageous. This negligible increase in aneurysm diameter (1.2 mm at 0 mmHg, 0.6 mm at 100 mmHg and 0.1 mm at 180 mmHg) is not seen in other endovascular treatment methods. The stent primarily absorbs stresses and it also preserves the native function of the vessel.

The aneurysm wall compliance reduced by 50% after stent deployment. The aortic diameter variation ([Table 1](#t1){ref-type="table"}) during a cardiac cycle (Blood pressure from 100 to 180 mmHg) reduced from 2.6 mm without stent to 1.4 mm with embedded stent, and 1.2 mm with embedded stent and significant tissue overgrowth.

Stage 3 study results of stents with various strut dimensions after embedding
-----------------------------------------------------------------------------

Stage 3 study results have shown a significant reduction in the aortic wall stresses by all the 3 stents with various strut thicknesses. Stress values and distribution in the aneurysm are similar in the investigated cases. However, smaller struts reduce the higher stress value at the aneurysm ends ([figure 6](#f6){ref-type="fig"}). [Table 2](#t2){ref-type="table"} summarizes the results of aortic diameter variation with stents of various strut dimensions. At zero pressure larger struts correspond to higher aortic diameter (AD). When the pressure rises larger struts are stiffer and tend to reduce the AD increment. Larger struts reduced AD variation efficiently during a cardiac cycle.

Discussion
==========

This is a proof of concept analysis, which demonstrates the theoretical potentials of the novel Nitinol based self-expanding stent in the treatment of aortic aneurysm. The stent had a good radial strength, and it reduces maximal stress distribution in aneurysm wall by more than 70%. The stent is novel as it is very large in diameter (70 mm) with a low crimp profile, and large (9 mm) cell width with an adequate radial force (1 to 5 N), and it also hugs the entire wall of the aneurysm sac in all dimensions, which is conceptually unique. The currently available largest diameter of an uncovered or bare peripheral arterial stent is only 14 mm. Commercially available uncovered venous stents have a maximum diameter of 28 mm (Sinus stent, Optimed). Balloon expandable uncovered Palmaz- Genesis (Cordis) peripheral stent has a maximal dimension of 22 mm, which is expandable to about 26 mm.

This method is conceptually very different from the endovascular stent grafts, which is bulky, expensive and technically demanding, and it is associated with various complications[@b7][@b8][@b9][@b10]. Also, this is distinctly different from the multilayered flow diverting stent which functions by inducing thrombosis in the multilayered stent to exclude the flow to the aneurysm wall to a significant extent[@b11][@b12]. This method could also be initiated as an initial method of therapy, which could be adequately revised with endovascular stent grafts or flow diverting stents in later stages of disease progression, if required.

The study stent\'s width is 70 mm in maximum diameter. The stent has a low crimp profile of 9 F compared to that of stent grafts (18--21 F minimum) for a caliber of \> 40 mm stent-graft. Hence, surgical arteriotomy would not be required in our method, and also the puncture site complications, which could be at times be life threatening, would be minimal.

Before stenting, the stress inside the aneurysm wall was two times higher than in the healthy aortic wall (0.30 vs. 0.15 MPa at BP = 100 mmHg). After stenting and stent embedding, the stress on the aneurysm wall was reduced by \~70% (from 0.30 to 0.10 MPa at Blood pressure of 100 mmHg, from 0.40 to 0.15 MPa at BP = 180 mmHg), and it was lower than the stress in the healthy aorta (0.15 MPa at BP = 100 mmHg and 0.25 MPa at Blood Pressure = 180 mmHg). The higher beneficial effect at 180 mmHg could be due to reduction in compliance, and a higher elastance and windkessel effect at that pressure (180 mmHg). When the wall stress reduces the risk of aneurysm rupture would be less as shown in computational and in-vivo studies[@b13][@b14][@b15][@b16][@b17].

The stent could be easily deployed in the aneurysm model, and the crimp profile was moderate (9 F). This low crimp profile is comfortable for any basic operator to use. The stent mildly increased the aortic aneurysm diameter size by about 1.2 mm ([Table 1](#t1){ref-type="table"}). A stent embedded in the aneurysm wall decreased the aneurysm wall compliance by more than 50%, and there was a marked decrease in the aneurysm diameter change at 100 mmHg and 180 mmHg, which is a reduction from 2.6 mm to1.2 mm. The impact of the 9 mm cell size stent on aortic shape, stresses, and strains are negligible with respect to the impact of blood pressure. The stent did not increase the stresses and strains in the aortic aneurysm wall after deployment ([Figure 3](#f3){ref-type="fig"}). This was essential to prove the concept that the method does not harm the existing aneurysm and the adjacent aorta, as the primary concept appears counter-intuitive.

Stent migration did not occur when modeling at a blood pressure of 180 mmHg, which is another important observation in the study. This could be due to self-expanding nature and good apposition of the stent onto the aortic wall, and also due to fixation of the stent by the barbs.

The impact on the daughter artery by the stent was negligible by pressure analysis. The daughter artery had a diameter of 7 mm and the cell width of the stent was 9 mm, which is adequate to maintain blood flow easily in the daughter artery. The current commercially available peripheral stents[@b18][@b19] have a cell width of about 2 mm. Hence, after deployment of a conventional stent in this model about 12 meshes would be across the origin of the daughter artery, whereas only one cell crosses the origin with the described design of 9 mm cell width. Hence, this stent has a very high probability of preservation of flow in the daughter artery. Though clot formation is mediated by platelets, the trigger by metal load, due to the crossing struts would be significantly lower in the current stent method due to wider cell widths. When compared to endovascular repair where the daughter artery is entirely excluded, this stent due to wider cell widths could easily preserve the side branches. Compared to the flow diverting stents the theoretical probability of side branch occlusion would be minimal as this method is single layered. The stresses at the origin of the daughter artery were reduced after deployment of the stent when compared to baseline ([Figure 5](#f5){ref-type="fig"}, panels 3 and 4).

At the edges of the stent, there were no abnormal stresses on the normal aorta as this is very essential to prove that the stent does not harm the normal adjacent aorta. The effect was more pronounced in stents with thinner (70/70 and 180/100 μm) struts, than stents with thicker struts (300/150 μm, [figure 6](#f6){ref-type="fig"}). The effect of the stent on the aneurysm\'s wall stresses needs to be studied further over a period of time.

The stent had maximal reduction in the wall stresses when it is embedded and with a tissue overgrowth. The method does not have any benefit without embedding the stent in the aortic wall. In real life situation, there will not be an adequate tissue cover over the entire stent. Hence, the results in real life situation would be in-between panels 3 and 4 in [Figure 5](#f5){ref-type="fig"}. The success of this method depends on embedding the stent and promoting tissue overgrowth, which is a part of vascular remodeling after stent deployment[@b20][@b21][@b22][@b23]. To enhance tissue overgrowth the stent could be coated with a polymer base as a carrier with vascular endothelial or fibroblastic growth factors. Though speculative, biological materials or hydrogels may be used for better adhesion of the stent, and possibly this would enhance tissue proliferation. For instance, certain hydrogels are useful to enhance tissue engineering and growth of scaffolds[@b24], and studies have demonstrated manipulations in overlying endothelial cells can have changes in the underlying extra-cellular matrix and smooth muscle cells[@b23][@b25]. In economic perspectives, smearing of alcohol in appropriate concentrations or perhaps pluronics on the stent could be used to study tissue proliferation. The effect of overlapping two stents with a different design in the same model needs to be evaluated further.

In the past, wall stent has been modeled mathematically as a bare stent, and it was compared with endovascular graft prosthesis in the treatment of aneurysms[@b26]. In this mathematical analysis[@b26], the wall stent had a maximum diameter of 24 mm only, and it was used as a skeleton of endovascular prosthesis and analysis was performed compared to stent graft. Hence, the concept in the mathematical modeling was very different from our stent method developed in this study by finite element analysis.

Multiple wall stents have been use in the therapy of aneurysm[@b27][@b28]. Conceptually in this study from China, where flow diversion stents were not available, the wall stents were deployed serially. They were used to form like a flow modular or diversion stent, and they cover the entire segment i.e. normal-normal segment across the aneurysm, and the stents diameter ranged from 20 to 28 mm only. Tang Xiao et al reported a significant negative result with that technique[@b28].

Computational and in-vivo studies in the past have proved that reduction of wall stresses result in a significant reduction in the rate of growth of aneurysm[@b29][@b30][@b31][@b32]. This study stent technique is distinctly different from multilayered stent, which excludes the flow and does not appose on the aneurysm wall.

This self-expanding stent method by reducing the wall stress would prevent aneurysm expansion. However, this may not help in aneurysm shrinkage, which would be ideal. This method could be used as an adjunct therapy to endovascular repair if many segments are involved or it can be used as a palliative measure when surgery or endovascular repair is not feasible, in a patient with other associated severe co-morbidities seen in various clinical scenarios.

The study was performed in finite element analysis, and the results may vary in a patient model. However, finite element analysis method is a widely accepted method of evaluation, and previous simulation studies have correlated the usefulness of this method in various scenarios requiring virtual stent evaluation[@b33]. Further testing of the method needs to be performed in animal models.

The results of variations due to individual patient anatomy need to be studied further. We investigated an idealized geometry of the aneurysm model. The effect of deployment of the device in a more complex patient based geometrical model with or without thrombus need to be studied. In individual cases with complex geometry, a patient based shape of the stent would be required. We presume complete apposition between the stent and aneurysmal wall, but in real life this is usually not the case as there is frequently some mural thrombus in the aneurysmal sac.

It should be emphasized that the presented simulations merely serve, as an indicative virtual proof-of-concept, and further in vitro and in vivo validation of the proposed concept seems highly advised. It should be stressed that the performed virtual tests may not be indicative of clinical performance without the previously mentioned necessary validation and verification.

Methods
=======

Strut selection for stage 1 and 2 analysis
------------------------------------------

A self-expanding stent design model was developed initially with a stent strut thickness of 70 μm and 70 μm width. The study was done in 3 stages. In the first stage, the 70/70 μm stent was chosen for study. The conventional existing peripheral stents have stent thickness of 200 μm. Hence, for stage 1 evaluation, we chose a stent with thin struts of 70 μm thickness and in the higher side for stage 2 analysis, a stent thickness of 300 μm was chosen. In the beginning of the study we anticipated the stent to increase the aneurysm wall stresses due to its self-expanding nature, and hence a thin stent with a benchmark of 70/70 μm (thickness/width) was chosen for initial analysis. This is to demonstrate its efficacy, and the harmless nature of the stent on the aneurysm wall, and the adjacent normal aortic wall on either edges of aneurysm.

Aneurysm model creation, stent design development and deployment characteristics
--------------------------------------------------------------------------------

Simultaneously, the deployment characteristics of the stent were studied. [Figure 7](#f7){ref-type="fig"} (upper panel) shows the aneurysm model, which is 6 cm in maximum diameter and 6 cm in length. We chose a 6 cm diameter virtual aneurysm model for the study, as a higher diameter aneurysm size i.e. 6.5 cm in the current medical practice would be a recommendation for surgical correction. The stent was 10 mm more than the aneurysm model in width, and there was a 10 mm extension of the stent beyond the aneurysm on either end to the normal aorta, to study the properties of the stent on adjacent normal aorta after deployment ([Figure 1](#f1){ref-type="fig"}). The aneurysm model and the disposition of the deployed stent are shown in the [supplementary file](#s1){ref-type="supplementary-material"}. The deployed stent was in contact with aorta and aneurysm wall in systole and diastole. The stent was oversized to compensate for any foreshortening of the stent during deployment inside the aneurysm in all dimensions, and also for better apposition in the aortic and aneurysm\'s wall due to its self expanding nature. In real life situation, mild foreshortening after deployment is expected due to inaccuracy in the calculation of aneurysm dimensions, the presence of clots, fluid structural interactions and insignificant buckling in the stent due to large stent with its self-expanding nature. Balloon angioplasty was not performed after deployment as this can weaken or damage the aneurysm and adjacent normal aortic wall.

The stent that was designed first had a 70/70 μm square struts. After testing this basic stent model, parametric modifications of the stent thickness and cell width were done, and the study was performed. The stent and aneurysmal properties were studied after changing the cell widths parametrically. After parametric adjustments, we limited the stent for evaluation at 9 mm cell width and 300/150 μm. This is due to its non-buckling nature, and higher radial force on the aneurysm wall with this 300/150 μm compared to other stents with various strut thicknesses.

The daughter artery was modeled, and it is functionally equal to a major branch of the aorta, for example, a single renal artery. The daughter artery had a luminal diameter of 7 mm and wall thickness of 0.7 mm, and it had a luminal connection with the aneurysm. The origin of the daughter artery was 60 degrees from the aneurysm wall. Several stent designs were generated, both with straight or helical patterns, and with different cell sizes ([Figure 7](#f7){ref-type="fig"}, Panel B). The stent was first crimped and then released in the aortic lumen.

Finite element analysis
-----------------------

For finite element modeling of aorta hyper-elastic matrix models of element type S4 (quadrilateral shells) was used[@b34]. Total number of elements in the aorta was 5040 (thickness of 1.5 mm) and the total elements in tissue overgrowth were 2171 (thickness of 1 mm). The nitinol material was a user subroutine of Abaqus[@b35]. For the nitinol material model the Abaqus subroutine for beam elements with 14 parameters was used. It models a possible Nitinol material at body temperature as described by Conti et al[@b35]. The total number of elements used were 4160 with element type of B31 (linear beams) with rectangular cross section. Modeling of embedding was performed using TIE constraints between tissue and the stent. The mesh sensitivity analysis was not performed. However, the mesh of stent was varied from 600 to 6000 elements and the mesh was chosen based on variation \< 5% of peak radial force during radial force testing of 300/150 μm stent with 9.5 cell unit ([Figure 4](#f4){ref-type="fig"}). The mesh of the aneurysm\'s maximal diameter when inflated with a pressure of 180 mmHg changed by \< 1% when doubling the number of elements.

The radial force testing was performed using a virtual rigid cylinder to decrease the stent diameter. The crimper was modeled using surface elements (FM3D4R). To simulate virtually the deployment of the novel stent into the aneurysm, the stress-free stent was first crimped using a crimping surface shaped as a cylinder with conical ends and then released inside the aorta. This release mechanism was simulated by activating the contact between the stent and aorta and thereby, increasing the radius of the crimping surface to a value above the aortic radius.

The stent was initially tested for buckling properties in cross sectional finite element analysis using Abaqus Explicit Solver, Simulia, 2012. The analysis was performed as quasi-static, ensuring that the kinetic energy was below 5% of the total energy. At cell width of 9 mm, there was no buckling of the stent.

Buckling properties, hemodynamic parameters and radial force measurements
-------------------------------------------------------------------------

Buckling of stent during deployment would lead to inadequate apposition of the stent in aneurysm wall and reduce its ability to absorb wall stresses and remodeling of the wall. Hence, the 9 mm cell-width stent was chosen, and it was loaded on a mandrel and the stent was deployed inside the aneurysm. The stress-strain properties, contact pressures, the aortic and aneurysm shapes before and after stent implantation in the aneurysm were studied at 0, 100 and 180 mmHg. These pressures were chosen to maintain uniformity in observations and analysis of results in the study, and also for veracity. Blood pressure\'s upper limit was fixed at 180 mmHg, as in real life situation a blood pressure control to ≤ 180 mm Hg could be easily achieved by pharmacological measures. Except for stage 1 study, which was an initial proof-of-concept analysis to demonstrate the safety and feasibility of this new technique, in all other experiments, the upper limit of blood pressure for evaluation was fixed at 180 mmHg to maintain uniformity. In stage 1 study, the upper limit of blood pressure was fixed at 160 mmHg arbitrarily. The stent was of Nitinol material, and the aneurysm was an anisotropic hyper-elastic model. The aortic thickness was 1.5 mm and daughter artery\'s thickness was 0.7 mm. The stent strut dimensions (thickness/width) were increased to 180/100 μm and 300/150 μm. Thereafter, radial force testing on the aortic stent was done, and the results were tabulated. For radial force testing stent designs with 4 cell sizes were considered -- 4.8, 4.9, 7.9 and 9.5 mm and three strut thickness/width were considered -- 70/70, 180/100, 300/150 μm.

Stage 2 analyses with 300/150 μm stent after embedding
------------------------------------------------------

In stage 2 analyses, a prototype of 300/150 μm (thickness/width) stent was tested in the aneurysm model for its effect on maximal wall stresses. This was chosen as it had a greater radial force compared to other stent\'s strut dimensions (70/70 and 180/100 μm, [figure 4](#f4){ref-type="fig"}), and hence it would have better stiffness and apposition in the aneurysm wall. As the aneurysm wall occasionally has organized thrombus, a good radial force, essentially leads to better apposition of the stent.

Also, thicker or larger struts have a higher probability for tissue proliferation and better support to the aortic wall, and enhanced ability to absorb stresses. However, if the strut thickness is too high, it would lead to more damaging forces on the aortic wall due to the self-expanding nature of the stent. Hence the upper limit for evaluation was arbitrarily fixed at 300 μm for the stage 2 study. The stent was embedded in the aortic wall initially, and later a model was created with a tissue overgrowth cover of 1 mm ([Figure 8](#f8){ref-type="fig"}). This is an assumption that the stent may promote a tissue growth due to biophysical and chemical reaction, and a tissue cover would be formed over the entire stent after deployment.

Stage 3 analyses with all the stents after embedding
----------------------------------------------------

Subsequently, stage 3 analysis was performed using stents with struts (thickness/width) 70/70, 180/100 and 300/150 μm in similar aortic aneurysm models after embedding the stent in aortic wall with a tissue cover of 1 mm. Comparison of the ability of the stents to reduce aortic wall stresses was studied. The larger stent struts could help to proliferate tissue overgrowth better which needs to be studied in tissue cultures.
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![The upper panel shows an overlay of the stent over the aneurysm model.\
The stent is larger than the aneurysm and is deployed internally. The figure shows a cross sectional analysis of the stent deployed in 7.5 and 9 mm cell sizes. The cell width of 9 mm had no buckling as shown in the figure.](srep03630-f1){#f1}

![The upper panels show the aortic shape before and after stenting at 100 and 160 mmHg pressures.\
Stress and strain distribution, and the contact pressures in the aortic wall after deployment of 70/70 μm at 0 mmHg and 100 mmHg.](srep03630-f2){#f2}

![Stress distribution and strain of the aorta before and after stenting with the 70/70 μm Nitinol stent at 160 mmHg.](srep03630-f3){#f3}

![Results of the radial force testing of the stents at various (70/70, 180/100 and 300/150 μm) strut dimensions.](srep03630-f4){#f4}

![The maximal stress distribution pattern in the aortic wall after deployment of 300/150 μm in the wall at 100 mmHg and 180 mmHg is depicted.\
There are 4 panels. The first panel has no stent, the second panel has stent deployed, the third panel has the stent embedded, and the fourth panel shows the stent embedded with tissue growth.](srep03630-f5){#f5}

![The maximal stress distribution pattern in the aortic wall after deployment of stents with strut thickness of 70/70, 180/100 and 300/150 μm\'s in the aortic wall, at 100 mmHg and 180 mmHg is depicted.](srep03630-f6){#f6}

![The aneurysm model used in the study is shown in Panel A. Panel B shows the helical and straight pattern of the stents developed in the study for testing.\
Panel C shows the enlarged view of the helical pattern of the stent used.](srep03630-f7){#f7}

![The aneurysm model before and after deployment of 300/150 μm stent is shown.\
The stent was embedded and thereafter a model was created with a tissue overgrowth of 1 mm.](srep03630-f8){#f8}

###### The aneurysm diameter (AD) is shown with or without stent deployment and the results after embedding the stent into the aortic wall and thereafter, with a tissue overgrowth of 1 mm over the 300/150 μM stent

  Maximum aneurysm diameter, (mm)    No stent   Stent not embedded, no overgrowth   Stent embedded, no overgrowth   Stent embedded, 1 mm tissue overgrowth
  --------------------------------- ---------- ----------------------------------- ------------------------------- ----------------------------------------
  AD~0~ (0 mmHg)                       59.4                   60.7                              60.7                                 60.7
  AD~100~ (100 mmHg)                   65.8                   66.1                              64.1                                 63.2
  AD~180~ (180 mmHg)                   68.4                   68.5                              65.5                                 64.4
  AD~180~--AD~100~                     2.6                     2.4                               1.4                                 1.2

###### Changes in aortic diameter after deployment of stents of various strut thickness. The stent was covered by aortic tissue and covered by 1 mm thick tissue overgrowth

  Maximum aneurysm diameter, (mm)    No stent   Stent 70/70 μm, after embedding   Stent 180/100 μm, after embedding   Stent 300/150 μm, after embedding
  --------------------------------- ---------- --------------------------------- ----------------------------------- -----------------------------------
  AD~0~ (0 mmHg)                       59.4                  59.3                               59.6                                60.7
  AD~100~ (100 mmHg)                   65.8                  62.7                               62.6                                63.2
  AD~180~ (180 mmHg)                   68.4                  64.5                               64.1                                64.4
  AD~180~--AD~100~                     2.6                    1.8                                1.5                                 1.2
